Broadcom (BRCM) May Lift Guidance as Analyst Day Approaches
Tweet Send to a FriendGet Alerts BRCM Hot Sheet
Price: $34.16 -1.33%
Rating Summary:
36 Buy, 2 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
36 Buy, 2 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade BRCM Now!
Ahead of Thursday's analyst day, Canaccord Genuity maintained a Buy rating on Broadcom (NASDAQ: BRCM) with a price target of $40.00.
Analyst Bobby Burleson said "upstream supply chain checks show positive momentum for BRCM's suppliers and indicate potential upside to guidance".
"Specifically, we believe BRCM has increased orders to suppliers by over 5% for the remainder of Q4 and through Q1 versus our prior month's checks, driven by strong holiday season demand for consumer-centric devices," said Burleson.
For an analyst ratings summary and ratings history on Broadcom (NASDAQ: BRCM) click here. For more ratings news on Broadcom click here.
Shares of Broadcom closed at $32.17 yesterday, with a 52 week range of $27.59-$39.66.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst Bobby Burleson said "upstream supply chain checks show positive momentum for BRCM's suppliers and indicate potential upside to guidance".
"Specifically, we believe BRCM has increased orders to suppliers by over 5% for the remainder of Q4 and through Q1 versus our prior month's checks, driven by strong holiday season demand for consumer-centric devices," said Burleson.
For an analyst ratings summary and ratings history on Broadcom (NASDAQ: BRCM) click here. For more ratings news on Broadcom click here.
Shares of Broadcom closed at $32.17 yesterday, with a 52 week range of $27.59-$39.66.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- Wedbush Starts USG Corp. (USG) at Neutral
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Canaccord GenuityLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

